Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Kotaki
M
M
Uday
K
K
Henriquez
M
M
Blum
S
S
Dave
M
M
D000284:Administration, Oral; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D018798:Anemia, Iron-Deficiency / Q000517:prevention & control*; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000097:blood; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis
D003692:Delayed-Action Preparations; D005296:Ferrous Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin; C020748:ferrous sulfate; D005293:Ferritins; D007501:Iron